This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents. Top assignee: Tambo, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jesse M Mcfarland: Innovator in Antibody-Mayotansine Conjugates
Introduction
Jesse M Mcfarland is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His work focuses on enhancing therapeutic options for cancer treatment.
Latest Patents
Jesse M Mcfarland holds a patent for "Anti-HER2 Antibody-Maytansine Conjugates and Methods of Use Thereof." This patent describes the structures of anti-HER2 antibody-maytansine conjugates, which include a maytansinoid component and a modified sulfatasemotif. The patent also outlines methods for producing these conjugates and their applications in medical treatments.
Career Highlights
Jesse M Mcfarland is currently associated with Redwood Bioscience, Inc. His role at the company involves research and development of innovative therapeutic solutions. Despite having no patents attributed to him prior to this, his work has the potential to impact cancer therapies significantly.
Collaborations
He has collaborated with notable colleagues, including David Rabuka and Aaron Edward Albers. These partnerships have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Jesse M Mcfarland is an influential figure in the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work at Redwood Bioscience, Inc. showcases his commitment to advancing cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile